Market Overview

UPDATE: Jefferies Raises PT to $65 on CME Group on Long-Term Outlook

Share:
Related CME
How Jefferies Is Playing 7 Major Brokerages & Exchanges Before Earnings
Deutsche Bank Met With CME Management; Here's What Happened

Jefferies reiterated its Buy rating on CME Group (NASDAQ: CME) and raised its price target from $60 to $65.

Jefferies noted, "Last week we spent several days with the management team of CME Group. The focus of the meetings centered around OTC clearing and execution initiatives and the globalization of CME's products, all of which represent potential offsets to the current lackluster environment for trading. On a longer-term basis we see several structural changes that should drive accelerating growth at CME."

CME Group closed at $57.29 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
Apr 2015BarclaysMaintainsEqual-weight
Mar 2015JefferiesMaintainsBuy
Mar 2015Deutsche BankMaintainsBuy

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...